My Web Dashboard





SEO News: Serono and Syntonix to Pursue the Development of a Long-Acting, Inhaleable FSH Therapy to Treat Infertility (FinanzNachrichten)

Serono ( Nachrichten ) (virt-x: SEO and NYSE: SRA) and Syntonix Pharmaceuticals Inc. announced today that they have entered into an agreement under which the companies will evaluate Syntonix' FSH:Fc SynFusion(TM) products for further development.

read more...

Related News